Noninvasive technology tests for malaria without a blood sample -- COMPAMED Trade Fair
Menu

Image: Anatomical model of human pancreatitis; Copyright: JoPanwatD

JoPanwatD

Pancreas: nanoparticles for optimized cancer therapy

22.11.2023

Researchers from Göttingen and Karlsruhe have developed a new treatment approach for pancreatic cancer. The innovative method promises to be able to treat the disease in a more targeted way and with fewer side effects in the future. The therapy is now to be optimized for clinical application as quickly as possible.
Read more
Image: An employee with a hairnet and smock stands at a complex high-tech system in a green-lit room; Copyright: TU Dresden/IHM

TU Dresden/IHM

Project for microelectronics resarch in Germany launched

13.09.2023

The BMBF-funded project “Forschungslabore Mikroelektronik Deutschland (ForLab)” brings together 14 German universities active in microelectronics research. Through the ForLab project, they were able to invest in new facilities that will open up new areas of research.
Read more
Image: A graphic of blood cells flowing within the body.; Copyright: iLexx

iLexx

Noninvasive technology tests for malaria without a blood sample

10.08.2023

Yale researchers and CytoAstra develop cytophone, a laser-ultrasound platform for noninvasive malaria detection. Funding from Gates Foundation supports prototype development and testing in Burkina Faso. Improved sensitivity offers promising diagnosis and treatment potential, bypassing emerging antigen test challenges.
Read more
Image: Light-activatable liquid metal nanostimulant in cancer therapy; Copyright: Eijiro Miyako from JAIST

Eijiro Miyako from JAIST

Cancer photoimmunotherapy: novel liquid metal nanoparticles

09.08.2023

JAIST researchers create liquid metal nanoparticles (PEG-IMIQ-LM) for cancer treatment, merging photothermal therapy and immunotherapy. Disintegration delivers immunomodulants and tracks cancer cells in real-time. Immune checkpoint inhibitor enhances cancer removal. Promising for future cancer theranostics, with clinical trials anticipated in a decade.
Read more
Image: Sarah Du, Ph.D., inventor and an associate professor; Copyright: Alex Dolce, Florida Atlantic University

Alex Dolce, Florida Atlantic University

U.S. patent for portable tool to diagnose and monitor sickle cell disease

28.06.2023

In the United States, sickle cell disease affects about 100,000 people and about 2 million Americans carry this genetic mutation. The most common and serious problems caused by sickle cell disease are anemia, pain and organ failure – stroke affects about 10 out of 100 children who have this disease. The national median life expectancy for people who have sickle cell disease can reach up to age 50.
Read more
Image: ARC trial participant in active therapy: ARC Therapy is designed to deliver targeted, programmed spinal cord stimulation; Copyright: ONWARD Medical NV

ONWARD Medical NV

Kick-off: Marie Skłodowska-Curie Doctoral Network "ReWIRE"

06.04.2023

Through ReWIRE, next-generation scientists will be trained to develop translational breakthrough therapeutic solutions for patients with paralysis caused by traumatic spinal cord injuries.
Read more